BioCentury
ARTICLE | Company News

Dendreon licenses Bayer antigens

September 26, 2001 7:00 AM UTC

Bayer (FSE:BAYG) granted DNDN licenses to two of its cancer antigens: carcinoembryonic antigen (CEA) and MN antigen, for use in DNDN's cancer vaccine research. CEA is expressed in multiple cancers, in...